The estimated Net Worth of Allan C. Golston is at least $1.13 Million dollars as of 17 May 2024. Mr. Golston owns over 2,207 units of Stryker stock worth over $808,534 and over the last 14 years he sold SYK stock worth over $0. In addition, he makes $325,107 as Lead Independent Director at Stryker.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Golston SYK stock SEC Form 4 insiders trading
Allan has made over 16 trades of the Stryker stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 2,207 units of SYK stock worth $808,534 on 17 May 2024.
The largest trade he's ever made was exercising 10,465 units of Stryker stock on 29 May 2020 worth over $618,377. On average, Allan trades about 1,075 units every 128 days since 2011. As of 17 May 2024 he still owns at least 2,207 units of Stryker stock.
You can see the complete history of Mr. Golston stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Allan Golston biography
Allan C. Golston serves as Lead Independent Director of the Company. He is a President, United States Program for the Bill & Melinda Gates Foundation since 2006, and Chief Financial and Administrative Officer of the Bill & Melinda Gates Foundation from 2000 to 2006. Mr. Golston is also a director of Harley-Davidson, Inc., a manufacturer of motorcycles and accessories. Mr. Golston has extensive experience in auditing, finance and the healthcare industry. He is a Certified Public Accountant and has held positions as a finance executive with Swedish Health Services (Seattle, WA) and the University of Colorado Hospital. In his service to the Gates Foundation, he has contributed to the strategic formation and operation of successful initiatives to provide healthcare, education and other human needs, all of which give him understanding that will assist Stryker in our global efforts to meet the needs of patients and caregivers. Additionally, Mr. Golston's expertise in financial matters enables him to make valuable contributions to our Audit Committee and his overall experience positions him well to serve as our Lead Independent Director.
What is the salary of Allan Golston?
As the Lead Independent Director of Stryker, the total compensation of Allan Golston at Stryker is $325,107. There are 10 executives at Stryker getting paid more, with Kevin Lobo having the highest compensation of $14,974,800.
How old is Allan Golston?
Allan Golston is 53, he's been the Lead Independent Director of Stryker since 2018. There are 14 older and 6 younger executives at Stryker. The oldest executive at Stryker Corp. is Srikant Datar, 67, who is the Independent Director.
What's Allan Golston's mailing address?
Allan's mailing address filed with the SEC is HARLEY-DAVIDSON, INC., 3700 WEST JUNEAU AVENUE, MILWAUKEE, WI, 53208.
Insiders trading at Stryker
Over the last 21 years, insiders at Stryker have traded over $2,226,515,535 worth of Stryker stock and bought 219,711 units worth $9,400,673 . The most active insiders traders include Ronda E Stryker, Pat Stryker, and Jon L Stryker. On average, Stryker executives and independent directors trade stock every 6 days with the average trade being worth of $10,449,767. The most recent stock trade was executed by Viju Menon on 27 August 2024, trading 600 units of SYK stock currently worth $213,000.
What does Stryker do?
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan.
What does Stryker's logo look like?
Complete history of Mr. Golston stock trades at Harley-Davidson and Stryker
Stryker executives and stock owners
Stryker executives and other stock owners filed with the SEC include:
-
Kevin Lobo,
Chairman of the Board, Chief Executive Officer -
timothy Scannell,
President, Chief Operating Officer -
Glenn Boehnlein,
Chief Financial Officer, Vice President -
Robert Fletcher,
Vice President, Chief Legal Officer -
Viju Menon,
Group President - Global Quality and Operations -
Kevin A. Lobo,
Chairman, CEO & Pres -
Timothy J. Scannell,
Pres & COO -
Glenn S. Boehnlein,
VP & CFO -
Viju S. Menon,
Group Pres of Global Quality & Operations -
Robert S. Fletcher,
VP & Chief Legal Officer -
Allan Golston,
Lead Independent Director -
Andrew Silvernail,
Independent Director -
Roch Doliveux,
Independent Director -
Sherilyn McCoy,
Independent Director -
Rajeev Suri,
Independent Director -
Ronda Stryker,
Independent Director -
Srikant Datar,
Independent Director -
Mary Brainerd,
Independent Director -
Preston Wells,
Vice President - Investor Relations -
Yin Becker,
Vice President - Communications, Public Affairs and Corporate Marketing -
William Berry,
Principal Accounting Officer, Vice President, Corporate Controller -
M. Kathryn Fink,
Chief Human Resource Officer, Vice President -
M. Kathryn Fink,
VP & Chief HR Officer -
William E. Berry Jr.,
VP & Chief Accounting Officer -
Dana S. McMahon,
VP & Chief Compliance Officer -
Alan Douville,
VP, Chief Information Officer & Chief Information Security Officer -
Robert C. Cohen,
CTO and VP of Global R&D - Joint Replacement -
Louise Francesconi,
Director -
David Floyd,
Group President, Orthopaedics -
Bijoy Sagar,
VP, Chief Information Officer -
Howard E Jr Cox,
Director -
Graham A Mc Lean,
President, Asia-Pacific -
Lonny J Carpenter,
Group President -
Michael Damon Hutchinson,
General Counsel -
Katherine Ann Owen,
VP, Strategy and IR -
William R Jellison,
VP and CFO -
Curtis E Hall,
VP, General Counsel -
Steven P Benscoter,
VP, Human Resources -
Howard L Lance,
Director -
Donald M Engelman,
Director -
Andrew Grant Fox Smith,
President -
Michael P Mogul,
Group President -
Tony M Mc Kinney,
V.P., CAO -
Stephen P Macmillan,
President and COO -
Marcia S Kaminsky,
V.P., Comms. & Public Affairs -
Michael W Rude,
VP of Human Resources -
Curt R Hartman,
V.P., Finance -
Ramesh Subrahmanian,
Group President, International -
Scott P Bruder,
VP, Chief Med&Scientific Off. -
Luciano Cattani,
V.P. -
James E Kemler,
Vice President -
Thomas R Winkel,
Vice Pesident -
John W Brown,
Chairman and CEO -
Jon L Stryker,
10% owner -
Pat Stryker,
10% owner -
Jerome H Grossman,
Director -
John S Lillard,
Director -
Dean H Bergy,
Vice President, CFO & Secretar -
James R Lawson,
Vice President -
Gerard Thomas,
10% owner -
Stephen Si Johnson,
Vice President -
Mason Elizebeth S Upjohn,
10% owner -
Edward B Lipes,
Vice President -
William U Parfet,
Director -
Tatum Lisa M Skeete,
Director -
Rachel Ruggeri,
Director -
Giovanni Caforio,
Director -
James Andrew Pierce,
Group President -
Spencer S Stiles,
Group President